Newton and Fidelity have been busy positioning their American portfolios towards defensive plays suc...
Newton and Fidelity have been busy positioning their American portfolios towards defensive plays such as healthcare and insurance. The fund managers are looking to miss the worst of a consumer and business slowdown possibly led by higher interest rates, now at 4%. Simon Laing, head of US equities at Newton, says the group's American fund is presently overweight healthcare, due to the government's Medicare reform programme, which will see seniors subsidised for healthcare insurance and drug needs. He believes this is positive news for the generic drug companies: sales should increase and...
To continue reading this article...
Join Professional Adviser for free
- Unlimited access to real-time news, industry insights and market intelligence
- Stay ahead of the curve with spotlights on emerging trends and technologies
- Receive breaking news stories straight to your inbox in the daily newsletters
- Make smart business decisions with the latest developments in regulation, investing retirement and protection
- Members-only access to the editor’s weekly Friday commentary
- Be the first to hear about our events and awards programmes




